Results 151 to 155 of about 22,199 (155)

CANCER PATIENTS AT RISK OF DRUG INTERACTIONS

Ca-A Cancer Journal for Clinicians, 2007
exaly  

Efforts to control prescription drug abuse: Why clinicians should be concerned and take action as essential advocates for rational policy

Ca-A Cancer Journal for Clinicians, 2014
exaly  

The evolving landscape of tissue‐agnostic therapies in precision oncology

Ca-A Cancer Journal for Clinicians
Vivek Subbiah, Bettina Ryll, Razelle Kurzrock   +2 more
exaly  

Review of: "The orphan drug dichloroacetate reduces amyloid beta-peptide production whilst promoting non-amyloidogenic proteolysis of the amyloid precursor protein"

2021
openaire   +1 more source

HuMax-CD4 [Genmab A/S] has received orphan drug status by the European Agency for the Evaluation of Medicinal Products

Inpharma Weekly, 2004
openaire   +1 more source